AU2186488A - Diagnosis and treatment of double stranded deficiency states - Google Patents

Diagnosis and treatment of double stranded deficiency states

Info

Publication number
AU2186488A
AU2186488A AU21864/88A AU2186488A AU2186488A AU 2186488 A AU2186488 A AU 2186488A AU 21864/88 A AU21864/88 A AU 21864/88A AU 2186488 A AU2186488 A AU 2186488A AU 2186488 A AU2186488 A AU 2186488A
Authority
AU
Australia
Prior art keywords
diagnosis
treatment
double stranded
deficiency states
deficiency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21864/88A
Other languages
English (en)
Inventor
William A. Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hem Research Inc
Original Assignee
Hem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Research Inc filed Critical Hem Research Inc
Publication of AU2186488A publication Critical patent/AU2186488A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
AU21864/88A 1987-09-04 1988-09-02 Diagnosis and treatment of double stranded deficiency states Abandoned AU2186488A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9352387A 1987-09-04 1987-09-04
US093523 1987-09-04

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU17366/92A Division AU1736692A (en) 1987-09-04 1992-06-03 Diagnosis and treatment of double stranded deficiency states

Publications (1)

Publication Number Publication Date
AU2186488A true AU2186488A (en) 1989-03-09

Family

ID=22239406

Family Applications (3)

Application Number Title Priority Date Filing Date
AU21864/88A Abandoned AU2186488A (en) 1987-09-04 1988-09-02 Diagnosis and treatment of double stranded deficiency states
AU17366/92A Abandoned AU1736692A (en) 1987-09-04 1992-06-03 Diagnosis and treatment of double stranded deficiency states
AU10014/95A Abandoned AU1001495A (en) 1987-09-04 1995-01-04 Diagnosis and treatment of double stranded deficiency states

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU17366/92A Abandoned AU1736692A (en) 1987-09-04 1992-06-03 Diagnosis and treatment of double stranded deficiency states
AU10014/95A Abandoned AU1001495A (en) 1987-09-04 1995-01-04 Diagnosis and treatment of double stranded deficiency states

Country Status (15)

Country Link
JP (1) JPH0825884B2 (xx)
KR (1) KR890005277A (xx)
CN (1) CN1031651A (xx)
AU (3) AU2186488A (xx)
CA (1) CA1336683C (xx)
DK (1) DK491088A (xx)
FI (1) FI884069A (xx)
IL (1) IL87664A (xx)
NO (1) NO883868L (xx)
NZ (1) NZ226033A (xx)
OA (1) OA08911A (xx)
PH (1) PH26320A (xx)
PT (1) PT88415B (xx)
RU (1) RU2001917C1 (xx)
ZA (1) ZA886581B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088344C (zh) * 1997-10-17 2002-07-31 青岛市卫生防疫站 富硒或富锌蚯蚓干粉或提取物的制造方法
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
JPS57200310A (en) * 1981-05-26 1982-12-08 Merck & Co Inc Local application of interferon inducer
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Also Published As

Publication number Publication date
KR890005277A (ko) 1989-05-13
OA08911A (en) 1989-10-31
PT88415B (pt) 1992-10-30
JPH0825884B2 (ja) 1996-03-13
CA1336683C (en) 1995-08-15
DK491088D0 (da) 1988-09-02
IL87664A (en) 1995-03-15
FI884069A (fi) 1989-03-05
DK491088A (da) 1989-03-05
RU2001917C1 (ru) 1993-10-30
AU1001495A (en) 1995-03-30
AU1736692A (en) 1992-07-30
IL87664A0 (en) 1989-02-28
JPH01131118A (ja) 1989-05-24
FI884069A0 (fi) 1988-09-02
NO883868L (no) 1989-03-06
NO883868D0 (no) 1988-08-30
PH26320A (en) 1992-04-29
NZ226033A (en) 1999-08-30
PT88415A (pt) 1989-07-31
ZA886581B (en) 1989-04-26
CN1031651A (zh) 1989-03-15

Similar Documents

Publication Publication Date Title
AU674894C (en) Treatment of conditions and disease
AU1409488A (en) Coagulation treatment of fluids
AU1676588A (en) Treatment of materials
AU623598B2 (en) Medical instrument and production thereof
AU2382588A (en) Medical instrument and production thereof
AU6434390A (en) Treatment of ards
AU6747887A (en) Treatment of skin disorders
AU1359388A (en) Hair treatment composition
AU6898287A (en) Treatment of bone loss
AU2169488A (en) Scalp treatment method
EP0506893A4 (en) Diagnosis and treatment of diseases
AU1279788A (en) Compounds and treatment
AU1595088A (en) Kernel oils and disease treatment
AU8269787A (en) Flyslag treatment
AU1369088A (en) Colony stimulating factors having reduced levels of carbohydrate
AU2135988A (en) Benzopyridazinone and pyridopyridazinone compounds and their use in the treatment of congestive heart failure
AU2186488A (en) Diagnosis and treatment of double stranded deficiency states
AU4849997A (en) Diagnosis and treatment of double stranded deficiency states
AU2297088A (en) Improved ovulation treatment
AU2564688A (en) Treatment of fibromyalgia
AU3989589A (en) Improved biosensor and the method of its use
AU8094887A (en) Water treatment compositions and processes
AU1834888A (en) Birth control and diagnostic methods
AU6765887A (en) Treatment of water
GB8722529D0 (en) Treatment of burns